FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 150 filers reported holding FATE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,427 | +14.6% | 673,290 | +157.4% | 0.01% | +16.7% |
| Q2 2023 | $1,245 | +225.9% | 261,611 | +590.0% | 0.01% | +140.0% |
| Q4 2022 | $382 | -100.0% | 37,915 | -64.3% | 0.01% | -80.8% |
| Q3 2022 | $2,378,000 | -29.5% | 106,125 | +86.6% | 0.03% | +23.8% |
| Q3 2021 | $3,371,000 | -65.9% | 56,876 | -50.1% | 0.02% | -76.9% |
| Q2 2021 | $9,889,000 | +570.0% | 113,943 | +601.6% | 0.09% | +203.3% |
| Q4 2020 | $1,476,000 | +232.4% | 16,241 | -43.2% | 0.03% | +42.9% |
| Q3 2019 | $444,000 | -23.8% | 28,603 | -20.2% | 0.02% | -76.9% |
| Q3 2018 | $583,000 | – | 35,845 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |